Patents by Inventor Masaki Terahara

Masaki Terahara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10925906
    Abstract: An object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function improving agent for neonates, comprising a lactic acid bacterium and/or a Bifidobacterium. The brain function improving agent or composition for improving brain function for neonates according to the present invention is advantageous in that the use thereof can improve the developmental quotient without any side effect and also enables effective development and growth of neonates.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: February 23, 2021
    Inventors: Satoshi Kusuda, Satsuki Totsu, Masaki Terahara
  • Patent number: 10517907
    Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: December 31, 2019
    Assignee: Meiji Co., Ltd.
    Inventors: Masaki Terahara, Takeshi Takahashi, Hiroyuki Itou
  • Publication number: 20190240268
    Abstract: Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.
    Type: Application
    Filed: March 14, 2019
    Publication date: August 8, 2019
    Applicants: MEIJI CO., LTD., SHIGA UNIVERSITY OF MEDICAL SCIENCE
    Inventors: Shigeki KOSHIDA, Masaki TERAHARA
  • Publication number: 20190201460
    Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.
    Type: Application
    Filed: March 14, 2019
    Publication date: July 4, 2019
    Applicant: Meiji Co., Ltd.
    Inventors: Masaki TERAHARA, Takeshi TAKAHASHI, Hiroyuki ITOU
  • Publication number: 20190201459
    Abstract: Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a bifidobacterium.
    Type: Application
    Filed: March 14, 2019
    Publication date: July 4, 2019
    Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCE
    Inventors: Shigeki Koshida, Masaki Terahara
  • Publication number: 20190134114
    Abstract: An object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function improving agent for neonates, comprising a lactic acid bacterium and/or a Bifidobacterium. The brain function improving agent or composition for improving brain function for neonates according to the present invention is advantageous in that the use thereof can improve the developmental quotient without any side effect and also enables effective development and growth of neonates.
    Type: Application
    Filed: April 12, 2017
    Publication date: May 9, 2019
    Applicant: Meiji Co., Ltd.
    Inventors: Satoshi KUSUDA, Satsuki TOTSU, Masaki TERAHARA
  • Publication number: 20180311289
    Abstract: Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.
    Type: Application
    Filed: October 19, 2016
    Publication date: November 1, 2018
    Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCE
    Inventors: Shigeki KOSHIDA, Masaki TERAHARA
  • Publication number: 20180303883
    Abstract: Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a bifidobacterium.
    Type: Application
    Filed: October 19, 2016
    Publication date: October 25, 2018
    Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCE
    Inventors: Shigeki KOSHIDA, Masaki TERAHARA
  • Publication number: 20180071346
    Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.
    Type: Application
    Filed: May 24, 2016
    Publication date: March 15, 2018
    Applicant: Meiji Co., Ltd.
    Inventors: Masaki TERAHARA, Takeshi TAKAHASHI, Hiroyuki ITOU
  • Patent number: 9314041
    Abstract: A probiotic lactobacillus was discovered from lactobacilli of the Lactobacillus genus independently isolated from human adult feces.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: April 19, 2016
    Assignee: MEIJI CO., LTD.
    Inventors: Toshihiro Sashihara, Makoto Yamaguchi, Yoshitaka Nakamura, Shuji Ikegami, Seiko Narushima, Katsunori Kimura, Shinya Nagafuchi, Masaki Terahara
  • Patent number: 7943124
    Abstract: The present invention relates to a composition for immunostimulation useful for promoting IgA and secretory component productions in mucosal tissues, comprising, alone or in combination, a cell of bifidobacterium belonging to Bifidobacterium bifidum or a processed product thereof, wherein the bifidobacterium has an activity to stimulate secretory component production and a high activity to stimulate IgA production, for example, it is a Bifidobacterium bifidum OLB 6377 strain or Bifidobacterium bifidum OLB 6378 strain.
    Type: Grant
    Filed: February 1, 2006
    Date of Patent: May 17, 2011
    Assignee: Meiji Dairies Corporation
    Inventors: Itaru Moro, Takashi Iwase, Kuniyasu Ochiai, Masako Yajima, Masaki Terahara, Yoshitaka Nakamura, Mamoru Totsuka, Kiyoshi Yamada
  • Publication number: 20090269321
    Abstract: A probiotic lactobacillus was discovered from lactobacilli of the Lactobacillus genus independently isolated from human adult feces.
    Type: Application
    Filed: February 23, 2006
    Publication date: October 29, 2009
    Inventors: Toshihiro Sashihara, Makoto Yamaguchi, Yoshitaka Nakamura, Shuji Ikegami, Seiko Narushima, Katsunori Kimura, Shinya Nagafuchi, Masaki Terahara
  • Publication number: 20090142374
    Abstract: The present invention relates to a composition for immunostimulation useful for promoting IgA and secretory component productions in mucosal tissues, comprising, alone or in combination, a cell of bifidobacterium belonging to Bifidobacterium bifidum or a processed product thereof, wherein the bifidobacterium has an activity to stimulate secretory component production and a high activity to stimulate IgA production, for example, it is a Bifidobacterium bifidum OLB 6377 strain or Bifidobacterium bifidum OLB 6378 strain.
    Type: Application
    Filed: February 1, 2006
    Publication date: June 4, 2009
    Applicant: MEIJI DAIRIES CORPORATION
    Inventors: Itaru Moro, Takashi Iwase, Kuniyasu Ochiai, Masako Yajima, Masaki Terahara, Yoshitaka Nakamura, Mamoru Totsuka, Kiyoshi Yamada